Non-viral vectors for RNA delivery

Y Yan, XY Liu, A Lu, XY Wang, LX Jiang… - Journal of Controlled …, 2022 - Elsevier
RNA-based therapy is a promising and potential strategy for disease treatment by
introducing exogenous nucleic acids such as messenger RNA (mRNA), small interfering …

Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis

WY Au, PPH Cheung - Bmj, 2022 - bmj.com
Objective To evaluate the effectiveness of heterologous and homologous covid-19 vaccine
regimens with and without boosting in preventing covid-19 related infection, hospital …

SARS‐CoV‐2 Omicron variant: characteristics and prevention

X He, W Hong, X Pan, G Lu, X Wei - MedComm, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) has brought about a great threat to global
public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS …

The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis

K Rahmani, R Shavaleh, M Forouhi… - Frontiers in public …, 2022 - frontiersin.org
Background Vaccination, one of the most important and effective ways of preventing
infectious diseases, has recently been used to control the COVID-19 pandemic. The present …

Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis

ZJ Madewell, Y Yang, IM Longini… - JAMA network …, 2022 - jamanetwork.com
Importance An overall household secondary attack rate (SAR) of 18.9%(95% CI, 16.2%-
22.0%) through June 17, 2021 was previously reported for SARS-CoV-2. Emerging variants …

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

DR Feikin, MM Higdon, LJ Abu-Raddad, N Andrews… - The lancet, 2022 - thelancet.com
Background Knowing whether COVID-19 vaccine effectiveness wanes is crucial for
informing vaccine policy, such as the need for and timing of booster doses. We aimed to …

COVID-19 vaccine boosters: the good, the bad, and the ugly

P Rzymski, CA Camargo Jr, A Fal, R Flisiak, W Gwenzi… - Vaccines, 2021 - mdpi.com
Pursuing vaccinations against COVID-19 brings hope to limit the spread of SARS-CoV-2
and remains the most rational decision under pandemic conditions. However, it does not …

Role of COVID-19 vaccines in SARS-CoV-2 variants

Z Zhou, Y Zhu, M Chu - Frontiers in immunology, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), is a threat to the health of the global population. As the result …

Association of COVID-19 vaccination with symptomatic SARS-CoV-2 infection by time since vaccination and Delta variant predominance

A Britton, KE Fleming-Dutra, N Shang, ZR Smith… - Jama, 2022 - jamanetwork.com
Importance Monitoring COVID-19 vaccine performance over time since vaccination and
against emerging variants informs control measures and vaccine policies. Objective To …

A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines

X He, J Su, Y Ma, W Zhang, S Tang - Frontiers in Immunology, 2022 - frontiersin.org
It is urgently needed to update the comprehensive analysis about the efficacy or
effectiveness of COVID-19 vaccines especially during the COVID-19 pandemic caused by …